Researchers have been trying to develop treatments for cancer for many years, only to fail. This is because even if some trials work, they always leave…
Category: biotech/medical – Page 1065
Were you unable to attend Transform 2022? Check out all of the summit sessions in our on-demand library now! Watch here.
Artificial intelligence (AI) has been steadily influencing business processes, automating repetitive and mundane tasks even for complex industries like construction and medicine.
While AI applications often work beneath the surface, AI-based content generators are front and center as businesses try to keep up with the increased demand for original content. However, creating content takes time, and producing high-quality material regularly can be difficult. For that reason, AI continues to find its way into creative business processes like content marketing to alleviate such problems.
Vocal biomarkers have become a buzzword during the pandemic, but what does it mean and how could it contribute to diagnostics?
What if a disease could be identified over a phone call?
Vocal biomarkers have amazing potential in reforming diagnostics. As certain diseases, like those affecting the heart, lungs, vocal folds or the brain can alter a person’s voice, artificial intelligence (A.I.)-based voice analyses provide new horizons in medicine.
Using biomarkers for diagnosis and remote monitoring can also be used for COVID-screening. So is it possible to diagnose illnesses from the sound of your voice?
Skin-like electronics could seamlessly integrate with the body for applications in health monitoring, medication therapy, implantable medical devices, and biological studies.
With the help of the Polsky Center for Entrepreneurship and Innovation, Sihong Wang, an assistant professor of molecular engineering at the University of Chicago’s Pritzker School of Molecular Engineering, has secured patents for the building blocks of these novel devices.
Drawing on innovation in the fields of semiconductor physics, solid mechanics, and energy sciences, this work includes the creation of stretchable polymer semiconductors and transistor arrays, which provide exceptional electrical performance, high semiconducting properties, and mechanical stretchability. Additionally, Wang has developed triboelectric nanogenerators as a new technology for harvesting energy from a user’s motion—and designed the associated energy storage process.
Due to their self-assembly function, DNA sensors have gained much attention as next-generation sensors that require an extremely low power supply.
Study: Spin transport properties in DNA & electrically doped iron QD organo-metallic junction. Image Credit: marie_mi/Shutterstock.com.
Scientists have recently used iron (Fe) quantum dots (QD) electrodes to determine the spin transport properties and quantum scattering transmission characteristics of DNA sensors at room temperature. This study is available in Materials Today: Proceedings.
Explaining the potential of nanotubes further, one of the lead researchers and associate professor at Johns Hopkins University (JHU), Rebecca Schulman told IE, “Tinier plumbing might help us analyze individual molecules, which could help us make better drugs or enzymes, separate toxins, or even create better batteries by designing the conduits that ions flow through rather than using a porous material.”
She believes that although these technologies are still 10+ years away, their foundation is in things like nano-plumbing and being able to precisely measure and control the pipes the plumbing is made of.
Nanotubes are a highly evolved version of nanopores, small DNA structures proposed in some previously published studies. A nanopore is designed to serve as a conduit across a thin barrier between two chambers. Examples of such barriers are cell membranes (nanopores allow things to move in and out of a cell) and across metal or graphene sheets (like in nanopore-enabled DNA sequencing).
A new study has identified an association between receiving an influenza vaccine and a reduced risk of stroke. The research is published in the journal Neurology.
Risk factors for stroke
A stroke occurs when the blood supply to the brain is cut off, causing damage to neuronal cells that in turn affects physiological functions in the body. There are different types of strokes that can occur: ischemic – where a blockage prevents blood from reaching the brain, hemorrhagic – caused by a bleed in or around the brain and transient ischemic attacks (TIA) which are strokes that last for a short amount of time. It’s estimated that one in four people aged 25 and over will be afflicted by a stroke in their lifetime.
👉For business inquiries: [email protected].
✅ Instagram: https://www.instagram.com/pro_robots.
The World Robot Conference 2022 was held in Beijing. Due to the ongoing offline pandemic, only Chinese robotics companies were represented, and the rest of the world joined in the online format. But the Chinese booths were also, as always, a lot to see. We gathered for you all the most interesting things from the largest robot exhibition in one video!
0:00 Intro.
0:30 Chinese robotics market.
1:06 EX Robots.
2:38 Dancing humanoid robot.
3:37 Unitree Robotics.
4:55 Underwater bionic robot.
5:23 Bionic arm and anthropomorphic robot.
5:43 Mobile two-wheeled robot.
6:40 Industrial robots.
7:04 Reconnaissance Robot.
8:05 Logistics Solutions.
9:31 Intelligent Platform.
10:03 Robot++
10:41 Robots in Medicine.
10:58 PCR tests with robots.
11:16 Robotic surgical system.
#prorobots #robots #robot #futuretechnologies #robotics.
More interesting and useful content:
Neuralink cofounder and Tesla CEO Elon Musk allegedly approached Synchron, a company that manufactures chips that can be implanted in patient’s brains.
When Neuralink co-founder Max Hodak announced his enigmatic departure from the company earlier this year, it was unclear whether he quit due to disagreements with fellow co-founder Elon Musk or if he was fired for moving too slow on clinical trials.
Now, Futurism has learned, Hodak is working on what appears to be a well-funded new brain interface venture called Science Corp. According to an SEC filing from July, Hodak has already raised more than $47 million from 14 investors for the new company — not quite as much as Neuralink’s $363 million to date, but a rousing start that could signal growing competition in the nascent neurotech market.
Moreover, Hodak appears to be taking some talent from Neuralink with him. Alan Mardinly, Neuralink’s longtime director of biology, recently changed his LinkedIn account to say that he has been working at a “stealth startup” since July 2021 and left his position at Neuralink in August 2021 — and posted a link to Science Corp’s hiring page along with an exhortation to “join early,” strongly suggesting that he’s on board the venture.